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H I G H L I G H T S
 Piﬁthrin-alpha (PFT) blocked docosahexaenoic acid (DHA)-induced cytotoxicity.
 The inhibitory effect of PFT on DHA-induced cytotoxicity was regardless of p53.
 PFT markedly inhibited DHA-induced induction of oxidative activity and autophagy.
 PFT signiﬁcantly suppressed the mitochondrial damage by DHA.
 Our data suggests that PFT has a p53-independent inhibition mechanism.
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A B S T R A C T
Piﬁthrin-alpha (PFT) is an inhibitor of p53 and is known to protect against a variety of p53-mediated
genotoxic agents. In this report, we examined the inhibitory effects of PFT against docosahexaenoic acid
(DHA)-induced cytotoxicity in the human hepatocellular carcinoma (HCC) cell line HepG2. PFT
signiﬁcantly abrogated DHA-induced cytotoxicity in wild-type HepG2 cells (normal expression of p53)
and after p53-knockdown by siRNA, as well as in Hep3B (p53 null) and Huh7 (p53 mutant) cells. DHA-
induced cytotoxicity is mediated by induction of oxidative stress, and PFT inhibited this event, but it does
not exert antioxidant effects. PFT signiﬁcantly suppressed the release of cytochrome c from mitochondria
to cytosol, as well as changes in the mitochondrial membrane potential (DCM) by DHA. Therefore,
protection of mitochondria by PFT is crucial for its inhibition of DHA-induced cytotoxicity. Although it has
been reported that PFT is able to block p53 function, our data suggest that PFT also has a p53-independent
inhibition mechanism. This work provided insights into the mechanisms of PFT action on DHA-induced
cytotoxicity in HCC.
ã 2014 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-
ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
1. Introduction
The tumor suppressor p53 is generally viewed as the most
direct and promising anti-cancer target. Although p53 as a
transcriptional factor is best known for controlling the cell cycle
and apoptosis, increasing evidence suggests that p53 is also
involved in induction of autophagy (Guo et al., 2013). The
pharmacological rescue of inactive p53 may therefore represent
an attractive therapeutic approach. Piﬁthrin-alpha (PFT) is an
inhibitor of p53 and is considered to be useful for therapeutic
suppression in order to reduce cancer treatment side effects
(Komarova and Gudkov, 1998) and to protect against various
genotoxic agents (Komarova et al., 2003). Several reports have
shown that PFT blocks the p53-mediated activation of autophagy
caused by chemical agents (Dong et al., 2012; Zhu et al., 2011). PFT
has been validated as a useful p53 inhibitor for the elucidation of
p53 functions in experimental studies.
It has been observed that docosahexaenoic acid (DHA), an
omega-3 polyunsaturated fatty acid, causes cancer cell death via
apoptosis (Gleissman et al., 2010; Lim et al., 2009; Wendel and
Heller, 2009). Along with apoptosis, autophagy has been
indicated to play a role in the cytotoxic mechanisms of DHA in
recent reports (Jing et al., 2011; Rovito et al., 2013; Yao et al.,
2014). Autophagy and apoptosis are self-destructive processes
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that share many key regulators, such as reactive oxygen
species (ROS). Physiological levels of ROS lead to growth adaption
and survival; however, excess ROS cause irreversible cellular
damage, thus provoking autophagy and/or apoptosis (Droge,
2002; Rubio et al., 2012). It has been shown that production of
ROS is a key mediator of DHA-induced cytotoxicity (Arita et al.,
2001; Maziere et al., 1999). A previous report has also shown that
DHA-induced cytotoxicity is mediated by oxidative stress, and the
cytotoxic effects are abrogated by typical antioxidants (Kanno
et al., 2011). Currently, DHA has potential applications in
chemotherapy; phase II clinical trials and randomized phase III
trials are currently underway (Hajjaji and Bougnoux, 2013).
Hepatocellular carcinoma (HCC) is the ﬁfth most common form of
cancer worldwide and the third most common cause of cancer-
related deaths (Raza and Sood, 2014). Safe and effective
chemotherapeutic reagents such as DHA are needed for use
against HCC, and it remains important to elucidate the cytotoxic
mechanisms of DHA against HCC.
As mentioned above, there have been several studies on the
cytotoxic mechanisms of DHA and the p53-dependent inhibitory
effects of PFT using experimental cell culture models, but it is
unknown whether PFT affects DHA-induced cytotoxicity in
human HCC cells. In this report, we examined the effects of
PFT on DHA-induced reductions in cell survival in HepG2 cells, as
well as the effects on p53 expression, oxidative stress, autophagy
and mitochondrial damage. This is the ﬁrst report to suggest that
PFT acts via a p53-independent mechanism against DHA-induced
cytotoxicity in HepG2 cells.
2. Materials and methods
2.1. Cell cultures and reagents
Human hepatoma HepG2, Hep3B or Huh7 cells were supplied
by the Cell Resource Center for Biomedical Research, Tohoku
University (Sendai, Japan). Cells were routinely kept in RPMI
1640 medium supplemented with 10% fetal bovine serum and
penicillin G (100 U/ml)/streptomycin (100 mg/ml) at 37 C in a
humidiﬁed 5% CO2-95% air incubator under standard conditions.
The drugs used in these experiments, piﬁthrin-a (PFT) orcis-4,
7, 10, 13, 16, 19-DHA (#D2534, 98%; Sigma, St. Louis, MO) and
all other reagents were of the highest grade available, and
were supplied by either Sigma or Wako Pure Chemical Industries
(Osaka, Japan). Cell culture reagents were obtained from Life
TechnologiesTM (Carlsbad, CA). DHA was dissolved in ethanol
and stored as a 200 mM stock solution, ﬂushed with argon, in
lightproof containers at 20 C. Light exposure was kept to a
minimum for all drugs used. All antibodies using for Western
blotting were purchased from Cell Signaling Technology
(Danvers, MA).
2.2. p53 siRNA knockdown assay
siRNA-p53 (si-p53) and siRNA-control (non-targeting siRNA;
negative control [Neg]) were transfected into HepG2 cells using
HyperFect transfection reagent (Qiagen, Valencia, CA) according to
the protocol supplied by the manufacturer. A non-targeting siRNA
was used as a control for the non-sequence-speciﬁc effects of
transfected siRNAs. The siRNAs (Qiagen) used were si-p53 from
FlexiTube siRNA (catalog no. SI00011655) and negative control
from AllStars Neg. Control siRNA (catalog no. SI03650318). Brieﬂy,
5 104 HepG2 cells containing each siRNA (ﬁnal concentration,
10 nM) and HyperFect reagent were incubated for 24 h for
assessment of p53 expression or cytotoxic effects by DHA.
2.3. RNA isolation and quantitative real-time polymerase chain
reaction assay
In order to conﬁrm knockdown by siRNA in HepG2 cells,
expression levels of p53 messenger RNA (mRNA) (GenBank
Accession no. NM_000546.5) were quantiﬁed by real-time
polymerase chain reaction (qPCR) with Light Cycler (Roche,
Basel, Switzerland). Brieﬂy, after transfection with siRNAs for 24 h
in HepG2 cells, total RNA was extracted from each cell line by
ISOGEN reagent (Nippon Gene, Tokyo, Japan), and RNA concen-
trations were determined by NanoDrop 1000 (Thermo Fisher
Scientiﬁc, Inc., Waltham, MA). From each sample, 0.1 mg of total
RNA was then reverse transcribed into single-strand cDNA using
an RverTra Ace1 qPCR RT Kit (Toyobo, Osaka, Japan). Aliquots of
cDNA preparations were then subjected to qPCR analysis on KOD
SYBR1 qPCR Mix (Toyobo) in order to quantitate the gene
expression of p53 and b-actin (GenBank Accession no.
NM_001101.3, internal standard) using Light Cycler. Primer pairs
were from the QuatiTect1 Primer Assay (p53, #QT00060235 or
b-actin, #QT00095431; Qiagen, Valencia, CA). The results of all
assays were checked against melting curves in order to conﬁrm
the presence of single PCR products. At least two independent
experiments were conducted and at least triplicate samples were
used in each experiment.
2.4. Western blotting
Cells were washed with phosphate buffered saline (PBS) and
lysed in CelLytic M1 (Sigma) in order to collect total cell lysates,
cytosol was separated and mitochondrial protein fractions were
collected using the Mitochondria Isolation Kit1 (Sigma) according to
the manufacturer’s instructions. Protein concentrations were
measured using a BCATM protein assay kit (Thermo Fisher Scientiﬁc,
Inc.) in accordance with the manufacturer’s instructions. Samples of
each protein (30mg of whole cell lysates, and 5 mg of eithercytosol or
mitochondrial protein) were loaded onto a 10–15% SDS-polyacryl-
amide gel. After electrophoresis, proteins were transferred to a
polyvinylidene diﬂuoride (PVDF) membrane. Protein was blocked
with Blocking One1 (Nacalai Tesque Inc., Kyoto, Japan) for 1 h, and
was reacted with antibody overnight at 4 C. Membrane was then
washed with buffer (PBS containing 0.05% Tween-20), followed by
incubation with horseradish peroxidase-linked secondary antibody
for 1 h. After washing, protein levels were analyzed by enhanced
chemiluminescence with Pierce1 Western blotting substrate
(Thermo Fisher Scientiﬁc, Inc.).
2.5. Cytotoxicity
Cytotoxicity was assessed by the water-soluble tetrazolium
(WST-1; sodium 5-(2,4-disulfophenyl)-2-(4-iodophenyl)-3-(4-
nitrophenyl)-2H tetrazolium inner salt) assay, which detects
metabolically competent cells with an intact mitochondrial
electron transport chain (Berridge et al., 2005). Brieﬂy, 1 104
cells were seeded into 96-well plates and cultured overnight.
Cells were pre-treated with PFT for 1 h, followed by incubation
with DHA for the indicated times, and addition of medium
containing WST-1 solution (0.5 mM WST-1 and 0.02 mM 1-
methoxy-5-methylphenazinium methylsulfate; 1-PMS) to each
well. Cells were incubated for 60 min at 37 C, and absorption at
438 nm (reference 620 nm) was measured using a SH-1200
Microplate Reader1 (Corona, Hitachinaka, Japan). Control cells
were treated with 0.1% ethanol. Cell viability was calculated
using the formula: absorbance in treated sample/absorbance in
control 100 (%).
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2.6. Measurement of oxidative stress
Intracellular oxidative stress was evaluated by measuring
intracellular peroxide-dependent oxidation of 20,70-dichlorodihy-
droﬂuorescein diacetate (DCFH-DA) to form the ﬂuorescent
compound, 20,70-dichloroﬂuorescein (DCF), as described previously
(Kanno et al., 2011). Results are expressed as a percentage of
ﬂuorescence intensity with respect to the control.
2.7. Total antioxidant capacity (TAC) assay
An oxidation system comprising 2,20-azino-di (3-ethylbenz-
thiazoline-6-sulfonic acid) (ABTS), myoglobin and hydrogen
peroxide (H2O2) has been used for TAC assay to determine Trolox
equivalent antioxidant capacity (Kambayashi et al., 2009; Yu and
Ong, 1999). We used this assay to assess the antioxidant capacity of
PFT. Brieﬂy, 90 mL of 10 mM phosphate buffered saline (pH 7.2),
Fig. 1. Effects of PFT on DHA-induced cytotoxicity in wild-type p53-expressing or p53 knockdown HepG2 cells. Each sample was transfected with (Neg: negative control; si-
p53: p53) or without (Mock) siRNA. (A) Effects of p53 knockdown by siRNA on p53 mRNA expression in HepG2 cells were assessed by quantitative real-time polymerase chain
reaction (qPCR). Results of qPCR are expressed as fold change in mRNA levels relative to Mock, using b-actin as an endogenous housekeeping gene. (B) Representative results
of Western blotting from three independent experiments. Each sample (n = 3–5) was extracted after transfection with siRNA for 24 h in HepG2 cells. Samples containing 30 mg
of protein were loaded onto 10% SDS-PAGE, and blots were probed with corresponding antibodies. b-actin levels were used as a loading control. (C) Data are means  SEM of
relative expression levels of p53 protein from three samples. **p < 0.01 compared with Mock group. (D) siRNAs transfected into HepG2 cells were incubated for 24 h, followed
by DHA treatment and examination for survival at 24 h. DHA-induced cytotoxicity in HepG2 cells was estimated by WST-1 assay. Survival (%) was calculated relative to no DHA
incubation (Mock). Results are expressed as means  SEM of three samples. White bars (&): single incubation with DHA; black bars (&): pretreatment with PFT at 20 mM for
1 h, and DHA incubation for 24 h at the indicated concentrations. **p < 0.01 compared with controls for each siRNA-transfected cell group; ##p < 0.01 compared with the
indicated concentrations of single incubation with DHA.
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50 mL of myoglobin solution, 20 mL of 3 mM ABTS solution, and
20 mL of PFT or Trolox solution were added to 96-well microplates.
Reactions were started by addition of H2O2 (ﬁnal concentration:
250 mM), and were followed at 600 nm with a microplate reader
for 10 min.
2.8. Immunoﬂuorescence assay as confocal ﬂuorescence microscopy
for detection of protein 1 light chain 3 (LC3) and cytochrome c
Cells were seeded into the Lab-Tek1 8-well chambered cover
glass system (Thermo Fisher Scientiﬁc, Inc.) at densities of 2  104,
and were incubated overnight under standard culture conditions.
Cells were pre-treated with or without PFT at 20 mM for 1 h,
followed by incubation with DHA at 120 mM for the indicated
times. Chambered slides were washed twice with phosphate
buffered saline (PBS). For detection of protein 1 light chain 3 (LC3),
cells were ﬁxed in ice-cold 1:1 methanol:acetone for 30 min. Slides
were immersed for 50 min in 1% goat serum and 0.1% Triton X-
100 in PBS, and were then transferred to 10% goat serum/PBS for
20 min. Following the PBS rinse, slides were incubated with
primary antibody (anti-LC3; MBL, Nagoya, Japan) at 1:1000 in PBS
for 1 h at room temperature, washed with PBS, and then incubated
with ﬂuorescein isothiocynate (FITC)-conjugated anti-rabbit sec-
ondary antibody (Beckman Coulter, Brea, CA) for 30 min. For
detection of cytochrome c, after incubation with reagents, the
medium was removed and cells were ﬁxed in Mildform1 (Wako,
Osaka, Japan) for 10 min. Slides were immersed for 5 min in 0.1%
Triton X-100 in PBS and were then transferred to 3% FBS/PBS for
30 min. After washing with PBS, slides were incubated with Alexa
Fluor1 555 mouse anti-cytochrome c antibody (BD PharmingenTM,
San Jose, CA) at 1:40 in PBS for 1 h. After incubation with
antibodies, rinsing with PBS and a drop of UltraCruzTM Mounting
Medium with DAPI (Santa Cruz Biotechnology, Inc., Dallas, TX) was
added to each well. Cells were observed under a confocal
ﬂuorescence microscope (C-1; Nikon, Tokyo, Japan) for blue
ﬂuorescence intensity (405 nm) indicating the nucleus, green
ﬂuorescence intensity (488 nm) indicating LC3-positive cells
(indicative of autophagy), or red ﬂuorescence intensity (562 nm)
indicating expression of cytochrome c.
2.9. Mitochondrial membrane potential (DCM) assay
In order to detect the effects of PFT and DHA on mitochondrial
membrane potential (DCM) in HepG2 cells, we used the Cell
Meter JC-10 mitochondrial membrane potential assay kit (AAT
Bioquest1, Inc., CA). JC-10 is capable of selectively entering the
mitochondria, and reversibly changes its color from orange to
green based on membrane potential. This property is due to the
reversible formation of JC-10 aggregates on membrane polariza-
tion that causes shifts in emitted light from 527 nm (i.e., emission
of JC-10 monomeric form) to 590 nm (i.e., emission of J-aggregate
form). Brieﬂy, cells were seeded at a density of 5 103 in Nunc
96 MicroWellTM optical bottom plates (Thermo Fisher Scientiﬁc,
Inc.) or into the Lab-Tek1 8-well chambered cover glass system
(Thermo Fisher Scientiﬁc, Inc.) at densities of 2  104, and were
incubated overnight under standard culture conditions. After
treatment with PFT and DHA for the indicated times, cells were
incubated with JC-10 dye-loading solution for 30 min, and
ﬂuorescence intensity in each well on the 96-well plates was
determined using a TECAN inﬁnite1 M1000 microplate reader
(Tecan Group Ltd.), or the cells were observed under a confocal
ﬂuorescence microscope C-1 (Nikon) for green ﬂuorescence
intensity (JC-10 monomeric form) or orange ﬂuorescence
intensity (J-aggregate form). The aggregate/monomer ratio is
assumed to be proportional to DCM intensity (Reers et al., 1995).
2.10. Statistical analysis
Statistical analysis was performed by one- or two-way analysis
of variance (ANOVA), followed by Williams’ type multiple
comparison test or the Bonferroni test among multiple groups.
Data are expressed as means  standard error of the mean (SEM). A
p-value of less than 0.05 was considered to be signiﬁcant.
3. Results
3.1. PFT decreased DHA-induced cytotoxicity independent of
p53 expression in HCC cells
First, in order to conﬁrm the effects of PFT against DHA-induced
cytotoxicity in HepG2 cells (wild-type expression of p53), we
established p53-knockdown HepG2 cells using siRNA (Fig. 1). After
transfection of HepG2 cells with siRNA-p53 (si-p53) for 24 h,
expression levels of p53 were signiﬁcantly lower at both the mRNA
(Fig. 1A) and protein (Fig. 1B and C) levels when compared to the
treatment control group (treatment with transfection reagent;
Mock) and the transfection control group (treatment with non-
targeting siRNA; negative control; Neg). Transfection with siRNA
did not affect cell survival. We examined the cytotoxic effects by
assessing mitochondrial activity (i.e., WST-1 assay). After trans-
fection with or without siRNA for 24 h, and following incubation
with DHA for 24 h, reductions in cell survival with DHA at 60,120 or
200 mM were 43.2  8.3, 19.2  9.6 or 7.1 4.3%, respectively, when
compared to the Mock group (Fig. 1D). Single incubation with DHA
concentration-dependently reduced cell survival to a similar
degree after transfection with Neg and si-p53. These cytotoxic
effects showed no signiﬁcant differences with the Mock group. In
the Mock group, PFT signiﬁcantly decreased DHA-induced
cytotoxicity at 60, 120 or 200 mM (83.1 8.2, 63.7  16.5 or
29.3  9.6%, respectively; p < 0.01), and this inhibition was
observed after transfection with Neg and si-p53. To further
evaluate the effects of PFT on DHA-related effects, we examined
DHA-induced cytotoxicity in cells with different p53 expression
states; Hep3B (p53 null cells) and Huh7 (p53 muted cells).
Fig. 2. Effects of PFT on DHA-induced cytotoxicity in Hep3B (p53 null) or Huh7
(p53 mutant) cells. Cells were pre-treated for 1 h with 20 mM PFT, followed by
addition of DHA at the indicated concentrations to culture medium, and further
incubation for 24 h. Survival (%) was calculated relative to controls. Results are
means  SEM of three samples. White bars (&): single incubation with DHA; black
bars (&): pretreatment with PFT, and incubation with DHA. **p < 0.01 compared
with controls, ##p < 0.01 compared with indicated concentrations of single
incubation with DHA.
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Similarly, single incubation with DHA showed concentration-
dependent reductions in cell survival, and PFT signiﬁcantly
inhibited the cytotoxic effects of DHA in both cell types (Fig. 2).
Thus, PFT abrogated DHA-induced cytotoxicity independently of
p53 expression.
4. PFT blocked DHA-induced oxidative stress and autophagy in
HepG2 cells
We examined the effects of PFT on DHA-induced oxidative
stress, as indicated by DCF ﬂuorescence (Fig. 3). Induction of
oxidative stress by DHA at 120 mM was signiﬁcantly elevated after
1 h of incubation (126.8  12.8%; p < 0.05), and increased further at
2, 4 and 6 h (154.2  8.1%, 196.6  32.8% and 229.8  20.3%,
respectively), as compared to controls (p < 0.01). These DHA-
induced increase in oxidative stress were abrogated by pretreat-
ment with PFT after incubation for 1 h (110.8  3.6%; p < 0.05), and
were further blocked by longer incubation for 2, 4 and 6 h
(113.8  12.4%, 106.5  2.3% and 103.9  12.2%, respectively; p
< 0.01). To conﬁrm the inhibitory effects of PFT on DHA-induced
oxidative stress and whether PFT has antioxidant capacity, we
performed TAC assay. As shown in Fig. 4, PFT does not show
antioxidant capacity when compared with Trolox, even at
2000 mM.
In order to explore the inhibition mechanisms of PFT on DHA-
induced cytotoxicity, we focused on the induction of autophagy
(Fig. 5). Levels of LC3A-II, which is an LC3-phosphatidyl-ethanol-
amine conjugate and a promising autophagosomal marker
(Asanuma et al., 2003), showed concentration-dependent
increases in incubation with DHA on Western blotting (Fig. 5A
and B). Expression was completely blocked by PFT. This inhibitory
effect of PFT was also observed in both Hep3B and Huh7 by
incubation with high concentrations of DHA at 200 mM (Fig. 5C and
D). On immunoﬂuorescence, PFT incubation for 24 h showed no
changes when compared with control groups, but the DHA-treated
group showed increased numbers of LC3-positive cells, and this
effect was apparently blocked by pretreatment with PFT (Fig. 5E).
Similarly, after transfection with pAcGFP-LC3 in HepG2 cells, PFT
blocked the formation of LC3 puncta in cells on incubation with
DHA (see Supplementary data 1).
Supplementry material related to this article found, in the
online version, at http://dx.doi.org/10.1016/j.toxlet.2014.11.016.
4.1. PFT decreased release of cytochrome c by DHA in HepG2 cells
Next, we examined the release of cytochrome c from
mitochondria to cytosol by DHA (Fig. 6). Cytochrome c is a critical
mediator of mitochondrial cell death. COX IV, a speciﬁc mitochon-
drial marker, was detected in mitochondrial fractions, indicating
good-quality mitochondrial preparations (Fig. 6A). Cytochrome c
decreased in the mitochondrial fraction and increased in the
cytosol fraction after incubation with DHA. On densitometric
measurement of bands on Western blotting (ratio is expressed as
cytosol/mitochondria fraction), single incubation with DHA for 1 or
4 h gave ratios of 0.95  0.15 or 1.33  0.29 when compared with
controls, and this release of cytochrome c was signiﬁcantly
suppressed by pretreatment with PFT (0.56  0.04, p < 0.01, and
0.83  0.14, p < 0.05, respectively; Fig. 6B). Similarly, on immuno-
ﬂuorescence observations, although PFT showed no changes in
cytochrome c expression when compared with control groups,
marked increases in cellular expression were seen after incubation
with DHA and these were attenuated by pretreatment with PFT
(Fig. 6C). Thus, PFT showed signiﬁcant suppression of cytochrome c
release from mitochondria to cytosol.
4.2. Effects of PFT on DHA-induced changes in mitochondrial
membrane potential (DCM).
In order to further investigate the mechanisms of cell death in
our study, we examined whether there were any changes in DCM
resulting in the stimulation of mitochondrial cell death. We
analyzed the effects on DCM using the JC-10 dyes (Fig. 7). JC-10 is a
membrane-permeable ﬂuorescent dye used for the measurement
of DCM. In intact cells, JC-10 concentrates in the mitochondrial
matrix where it forms orange ﬂuorescent aggregates. However, in
damaged cells, JC-10 diffuses out of mitochondria, changes to a
monomeric form and stains cells to show green ﬂuorescence. As
shown in Fig. 7A, PFT increased aggregate (orange) forms, but not
monomer (green) forms. The ﬂuorescence intensity of aggregate
forms was markedly higher after incubation for 1 h and persisted
Fig. 3. Effects of DHA-induced oxidative stress in HepG2 cells. Oxidative stress was
estimated by 20 ,70-dichloroﬂuorescein (DCF) ﬂuorescence assay, as described in
Section 2. Quantitative analysis of oxidative stress by HepG2 cells incubated in the
presence of DHA at 120 mM for the indicated times. Pre-treatment with PFT at
20 mM was performed for 1 h before incubation with DHA. The results are expressed
as a percentage of DCF ﬂuorescence intensity with respect to controls. Data are
means  SEM of three samples. White bars (&): single incubation with DHA; black
bars (&): pretreatment with PFT and incubation with DHA. *p < 0.05,
**p < 0.01 compared with controls, #p < 0.05, ##p < 0.01 compared with indicated
concentrations of single incubation with DHA.
Fig. 4. Total antioxidant capacity of PFT or Trolox. An oxidation system comprising
2, 20-azino-di (3-ethylbenzthiazoline-6-sulfonic acid) (ABTS), myoglobin and
hydrogen peroxide (H2O2) was used for TAC assay to determine Trolox equivalent
antioxidant capacity, as described in Section 2. Increases in absorbance at 600 nm
for 10 min were then recorded. Results are expressed as means  SEM of three
samples. Black bar (&): no incubation with reagent as control; white bar (&):
incubation with Trolox at 100 mM; striped bars (O): incubation with PFT at 20,
200 or 2000 mM. **p < 0.01 compared with control group.
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with incubation for up to 24 h, but there were no changes in
monomer forms (see Supplementary data 2). In contrast to PFT-
treated groups, DHA increased monomer forms, indicating
mitochondrial dysfunction, as compared with control groups.
Pretreatment with PFT partially blocked the increase in monomer
forms after incubation with DHA. On quantitative analysis of the
ratio of aggregate/monomer (Fig. 7B), single incubation with DHA
showed concentration- and time-dependent decreases in this
ratio, which indicates that DHA caused changes in DCM and
mitochondrial damage. Single treatment with PFT signiﬁcantly
increased the ratio to more than two-fold the levels seen in
controls (p < 0.01), while DHA-induced decreases in the ratio were
markedly attenuated by pretreatment with PFT after each
incubation period. Thus, PFT blocked DHA-induced changes in
DCM.
Supplementry material related to this article found, in the
online version, at http://dx.doi.org/10.1016/j.toxlet.2014.11.016.
5. Discussion
Early reports identiﬁed the production of reactive oxygen
species (ROS) as one of the mechanisms of DHA-induced
cytotoxicity (Arita et al., 2001; Maziere et al., 1999). The
transcriptional factor p53 plays a pivotal role in cell survival and
induction of ROS. In our initial hypothesis, we assumed that DHA-
induced cytotoxicity was mediated through p53 activation and the
subsequent signal transductions. This was based on the notion that
production of ROS and disruption of mitochondria, induced by
several cytotoxic agents, is associated with p53 activation (Raha
and Robinson, 2000). Our previous report showed that DHA-
induced cytotoxicity was mediated by induction of ROS, and
antioxidants inhibited the reduction of cell survival by DHA, but
this cytotoxic mechanism was not based on changes in p53 mRNA
expression, total levels or phosphorylation of p53 proteins in
HepG2 cells following incubation with DHA (Kanno et al., 2011). In
this report, single incubation with DHA showed concentration-
dependent cell survival reduction regardless of whether p53 was
expressed, and PFT, a p53 inhibitor, signiﬁcantly blocked DHA-
induced cytotoxicity (Figs. 1 and 2). Moreover, PFT signiﬁcantly
blocked DHA-induced oxidative stress (Fig. 3), but it showed no
antioxidant capacity on TAC assay (Fig. 4). This suggests that PFT
has another, p53-independent mechanism that is not related to
antioxidant capacity or ROS scavenging actions against DHA-
induced cytotoxicity in HepG2 cells.
Recent evidence supports the notion that induction of
autophagy occurs during the oxidative stress response (Kifﬁn
Fig. 5. Effects of PFT on DHA-induced autophagy indicating LC3 expression. (A and C) Western blots analysis of LC3 expression in whole cells. Each sample (n = 3–5) was
incubated for 12 h with DHA pre-treated with or without PFT. Samples containing 30 mg of protein were loaded onto 15% SDS-PAGE gels and blots were probed with antibody.
b-actin levels were used as a loading control. (B and D) Protein bands were quantiﬁed by densitometry and are expressed relative to expression levels of LC3A-II/LC3A-I.
**p < 0.01 compared with controls. (E) Immunoﬂuorescence observation of LC3 expression. Magniﬁcation: 1000. Fluorescence images were taken with a Nikon microscope.
Treatment with DHA at 120 mM for 12 h induced the appearance of LC3 expression (green ﬂuorescence) and this was blocked by pretreatment with PFT. (For interpretation of
the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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et al., 2006). In this report, DHA induced autophagy, as indicated by
LC3 expression on immunoﬂuorescence observation and Western
blotting (Fig. 5). This suggests that DHA-induced autophagy is
related to oxidative stress response, such as induction of ROS.
Nuclear p53 positively regulates autophagy in stressed cells
through transactivation of autophagy-related target genes (Liang,
2010). Jing et al. (2011) showed that inhibition of p53 increases
DHA-induced autophagy and prevention of p53 degradation
signiﬁcantly leads to attenuation of DHA-induced autophagy, thus
suggesting that DHA-induced autophagy is mediated by p53.
Recently, it was shown that inhibition of p53 by PFT led to impaired
activation of autophagy and enhanced chemosensitivity in HCC
during nutrient deprivation (Guo et al., 2014). In contrast, as shown
in Figs.1 and 2, PFT blocked DHA-induced cytotoxicity regardless of
p53 expression. This suggests that the effects of PFT may change
depending on other factors, such as experimental cell culture
conditions at individual facilities.
Autophagy is relevant to energy homeostasis (Singh, 2010), and
autophagy may exert its tumor-suppressing function at the
subcellular level by removing defective cytoplasmic components
such as damaged mitochondria (Hofer and Wenz, 2014). Mijaljica
et al. (2007) suggested that autophagy occurring subsequent to
cytochrome c release is trigged by changes in DCM; therefore, we
assumed that it plays a key role in mitochondrial damage by DHA,
Fig. 6. Effects of PFT on DHA-induced release of cytochrome c in HepG2 cells. (A) Western blot analysis of cytochrome c expression in mitochondrial and cytosolic protein
extracts. Cells were treated for the indicated times with DHA, with or without PFT pretreatment. Samples containing 5 mg of protein were loaded onto 15% SDS-PAGE gels and
blots were probed with corresponding antibodies. b-actin levels were used to conﬁrm the equal loading of cytosolic proteins and COX IV was used to conﬁrm the equal loading
of mitochondrial proteins. (B) Protein bands were quantiﬁed by densitometry, and are expressed relative to the expression levels of release from mitochondria to cytosol
fractions. White bars (&): single incubation with DHA; black bars (&): pretreatment with PFT and incubation with DHA. *p < 0.05, **p < 0.01 compared with controls.
#p < 0.05, ##p < 0.01 compared with each indicated concentration of single incubation with DHA treatment group. (C) Immunoﬂuorescence observation of cytochrome c.
Magniﬁcation: 1000. Fluorescence images were obtained with a Nikon microscope. Treatment with DHA at 120 mM for 4 h enhanced cytochrome c expression (red
ﬂuorescence), and this was attenuated by pretreatment with PFT. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of
this article.)
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and that PFT exerts some inﬂuence over mitochondria. Oxidative
damage has been shown to increase the permeability of the
mitochondrial membrane to various molecules and to result in
mitochondrial functional failure (Kifﬁn et al., 2006). Changes in
mitochondrial permeability are accompanied by depolarization of
the mitochondrial membrane and uncoupling of oxidation and
phosphorylation reactions in the mitochondrial lumen. Leakage of
intramitochondrial components, such as cytochrome c, constitutes
the ﬁrst step in activation of various cellular death programs
(Assuncao Guimaraes and Linden, 2004). It should be speciﬁed
that the release of cytochrome c (among other mitochondrial
constituents) is not sufﬁcient to trigger a cascade of apoptotic
events (Luzikov, 1999). As shown in Fig. 6, PFT apparently
suppressed the release of cytochrome c by DHA in HepG2 cells.
Fig. 7. Effects of PFT on DHA-induced changes in mitochondrial membrane potential (DCM), as indicated by mitochondrial ﬂuorescence probe JC-10. (A)
Immunoﬂuorescence observations of JC-10. Magniﬁcation: 1000. Fluorescence images were obtained with a Nikon microscope. Pretreatment with PFT for 1 h increased
J-aggregates (orange ﬂuorescence, 590 nm) and no changes monomeric form (green ﬂuorescence, 527 nm) were seen, as compared to control. Treatment with DHA at 120 mM
for 12 h induced increases in JC-10 monomeric form, and this was attenuated by pretreatment with PFT. (B) Quantitative results of aggregate/monomer ratio were assumed to
be proportional to DCM intensity. Results are expressed as means  SEM of three samples. White bars (&): single incubation with DHA; black bars (&): pretreatment with
PFT and incubation with DHA. *p < 0.05, **p < 0.01 compared with controls. #p < 0.05, ##p < 0.01 compared with indicated concentrations of single incubation with DHA. (For
interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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Thus, our results indicate that the inhibition mechanisms of PFT on
DHA-induced cytotoxicity and autophagy depend on mitochon-
drial damage.
It has not yet been shown that mitochondria are selected for
autophagy depending on the level of oxidative damage to their
membranes, but some evidence suggests that mitochondrial
permeability plays a role in the initiation of autophagy
(Lemasters et al., 2002; Mijaljica et al., 2007). As shown in
Fig. 7, single incubation with DHA showed concentration- and
time-dependent decreases in DCM after incubation for 12 h.
Fig. 3 and our previous report (Kanno et al., 2011) show that
DHA-induced oxidative stress signiﬁcantly increases after
incubation, and release of cytochrome c increases after incuba-
tion with DHA (Fig. 6). Interestingly, changes in DCM by DHA
were not observed before the detection of oxidative stress and
release of cytochrome c; changes in DCM occur in a compara-
tively later stage of DHA treatment. JC-1 (prototype of JC-10) is
reported to be a more reliable indicator of DCM than other dyes
(Mathur et al., 2000), and it has been indicated that J-aggregate-
forming lipophilic cations might be useful for probing DCM in
living cells (Reers et al., 1995). In this study, pretreatment with
PFT increased in J-aggregate formation under basal cellular
conditions (Fig. 7). It has been demonstrated that DCM controls
ROS production (Sanderson et al., 2013). Several reports have
shown that chemical reagent-induced elevation of DCM reduces
ROS production and indicates a cytoprotective effect. ()
Deprenyl is an irreversible inhibitor of monoamine oxidase-B,
which protects cells from hypoxia/re-oxygenization, maintains
DCM and prevents increases in ROS induced by hypoxia/re-
oxygenation in a dose-dependent manner (Simon et al., 2005).
1,2-Dimethylhydrazine treatment increases the formation of J-
aggregate at higher DCM, decreases ROS function and restricts
cell death (Saini and Sanyal, 2012). These reports suggest that
higher DCM protects ROS production and results in the
prevention of ROS-mediated cytotoxicity. We speculate that
PFT activates DCM in living cells, thereby increasing the
threshold of sensitivity produced by DHA-induced oxidative
stress. Thus, PFT may protect against mitochondrial damage by
DHA. It is conceivable that increases in J-aggregate represent
respiration or energy synthesis hot spots in the cells and may
protect against cellular injury by DHA. It is unclear how PFT
affects mitochondria and increases J-aggregate, and we are
therefore studying this issue further.
6. Conclusion
Based on the present results, we propose the following
mechanism for the effects of PFT against DHA-induced cytotoxicity.
First, pretreatment with PFT protects against DHA-induced
mitochondria damage by increasing DCM in living cells. Second,
PFT blocks the increase in oxidative stress and the release of
cytochrome c from mitochondria into the cytosol by DHA, but it
does not show antioxidant action under the present experimental
conditions. Hence, PFT inhibits mitochondrial damage and
induction of autophagy-mediated oxidative stress by DHA,
resulting in abrogation of DHA-induced cytotoxicity. However, it
is uncertain whether the pharmacological mechanisms of PFT on
mitochondrial function are fully p53 independent. Further studies
are necessary in order to clarify the molecular mechanisms of PFT
on DHA-induced cytotoxicity.
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